Health Affairs

Study: Patients with marketplace health plans spend less on medications

Study: Patients with marketplace health plans spend less on medications

By

Employer-insured enrollees spend more on prescriptions than health-insurance exchange enrollees, but the groups spend the same amount of money when it comes to specialty medications, a study shows.

Study: Considering cost would not change most care decisions

Study: Considering cost would not change most care decisions

By

A study found that cost-effectiveness and clinical-effectiveness measures often point to the same treatment protocol.

2013 healthcare spending crept upwards

2013 healthcare spending crept upwards

By

Centers for Medicare and Medicaid Services says it is too early to blame a sluggish economy for slow growth.

Can we handle cost of a healthy, aging population?

Can we handle cost of a healthy, aging population?

By

The short answer: we're not financially prepared for a slowly aging, healthy population, according to a recently published analysis.

CMS projects healthcare spending to rise

CMS projects healthcare spending to rise

By

Researchers says growth will average 5.8% a year between 2012 and 2022. They also anticipate generics will hit a leveling-off point that will drive average Rx prices upwards

Doctors could use more info on health exchanges: study

By

A new survey of doctors reveals how much they know (or don't) about the looming launch of healthcare exchanges.

Studies provide more clues to patient adherence, medical needs

By

Three studies take on different angles of the patient experience. Spoiler alert: no cost increases are mentioned.

Pill-plus value adds beat brand names in the age of ACOs

By

The effectiveness of new drugs is in decline, says an analysis, and researchers say comparative studies should look beyond efficacy measures.

High deductibles linked to lower Rx fills and cancer screenings

By

A study highlights medical service trends among patients with high-deductible plans but lacks insight on health impact and long-term costs.

Studies show cheaper drugs don't add up to greater use

By

Two studies released show that the story behind lower consumer healthspend isn't about generics improving health.

Business briefs: Baxter; Eli Lilly; CDHPs and Statins

Baxter's Alzheimer's treatment is out of the running; Eli Lilly has upped its layoffs; insured consumers are spending less on healthcare; stains and prostate cancer may have an amicable relationship; doctors aren't screening teens for HIV.

Congressmen spar over meningitis blame

By

Members of the House Energy and Commerce committee alternatively blamed and excused the FDA over the meningitis outbreak that has killed 32 patients.

Sites touting surgeries are one-sided, says study

By

The drug industry gets a lot of grief over its online communications to consumers, but a study has found that sites posted by doctors and hospitals and touting surgeries are often dreadful—and far less tightly regulated.

Study says docs favor COI disclosure

Study says docs favor COI disclosure

By

About 65% of the 1,800 physicians surveyed in a 2009 study discussed in Health Affairs support disclosing potential conflicts of interest to patients.


Email Newsletters


Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.